Georg Neckermann
Impact in
- Pharmaceutical Science top 10%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
-
- Drug Transport and Resistance Mechanisms
- Peptidase Inhibition and Analysis
Papers in
- Oncology 8
- Drug Transport and Resistance Mechanisms 4
- Peptidase Inhibition and Analysis 3
-
- Cancer therapeutics and mechanisms 2
- Co-authors
- Günther Wess (4 shared papers)Werner Kramer (4 shared papers)Josef G. Meingassner (2 shared papers)Gerrit Alexander Schubert (2 shared papers)Alfons Enhsen (3 shared papers)Karl‐Heinz Baringhaus (2 shared papers)Frank Girbig (1 shared paper)Ulrike Gutjahr (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (1 paper)Journal of Biological Chemistry (1 paper)Antimicrobial Agents and Chemotherapy (1 paper)
- Partner nations
- United StatesGermanyAustria
In The Last Decade
Georg Neckermann
12 papers receiving 280 citations
Peers
Comparison fields: 5 of 68
- Pharmaceutical Science 32
- Oncology 143
- Molecular Medicine 25
- Dermatology 34
- Microbiology 17
Countries citing papers authored by Georg Neckermann
This map shows the geographic impact of Georg Neckermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Georg Neckermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Georg Neckermann more than expected).
Fields of papers citing papers by Georg Neckermann
This network shows the impact of papers produced by Georg Neckermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Georg Neckermann. The network helps show where Georg Neckermann may publish in the future.
Co-authors
The 25 scholars most cited alongside Georg Neckermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 71 | |
| 2 | 2000 | 41 | |
| 3 | 1994 | 39 | |
| 4 | 1997 | 31 | |
| 5 | 2012 | 30 | |
| 6 | 2003 | 26 | |
| 7 | 2013 | 24 | |
| 8 | 2009 | 19 | |
| 9 | 1995 | 14 | |
| 10 | 2016 | 10 | |
| 11 | 1998 | 1 | |
| 12 | 2013 | 1 |
About Georg Neckermann
Georg Neckermann is a scholar working on Oncology, Molecular Biology, Pharmacology, Dermatology and Toxicology, having authored 12 papers that have together received 307 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (4 papers), Peptidase Inhibition and Analysis (3 papers), Urticaria and Related Conditions (2 papers), Dermatology and Skin Diseases (2 papers), Cancer therapeutics and mechanisms (2 papers), Microbial Natural Products and Biosynthesis (2 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Pediatric Hepatobiliary Diseases and Treatments (1 paper). The work is most often cited by research in Pharmaceutical Science (32 citations), Oncology (143 citations), Molecular Medicine (25 citations), Dermatology (34 citations) and Microbiology (17 citations). Georg Neckermann has collaborated with scholars based in United States, Germany and Austria. Frequent co-authors include Günther Wess, Werner Kramer, Josef G. Meingassner, Gerrit Alexander Schubert, Alfons Enhsen, Karl‐Heinz Baringhaus, Frank Girbig, Ulrike Gutjahr, Simone Kowalewski and Donghui Yu. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Journal of Biological Chemistry and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.